Mast Cell Tumors in Dogs: Grading, Treatment & Prognosis

Mast cell tumors, often shortened to MCTs, are cancers that arise from mast cells. These are immune cells found in the skin and other tissues that normally help with allergic and inflammatory responses. Because mast cells contain histamine, heparin, and other chemical mediators, a tumor made of these cells can cause both a visible lump and body-wide effects such as itching, swelling, stomach irritation, or ulcer formation.

In dogs, mast cell tumors are the most common malignant skin tumor. They are often called the "great pretender" because they can resemble a fatty lump, wart, bug bite, cyst, or irritated skin tag. Some stay small for a while. Others change quickly. A lump that seems to wax and wane in size is especially suspicious because tumor cells can degranulate and trigger local inflammation.

After removal or biopsy, pathologists usually grade canine cutaneous MCTs using the Kiupel 2-tier system as low-grade or high-grade. Some reports also include the older Patnaik 3-tier system. In general, low-grade tumors are less likely to spread and may be managed with surgery alone, while high-grade tumors are more aggressive and often need staging and multimodal treatment planning with your vet or a veterinary oncologist.

Not every mast cell tumor behaves the same way. Location, size, mitotic index, lymph node involvement, margin status, and whether the tumor has spread all influence prognosis. That is why two dogs with "mast cell tumor" can have very different treatment paths.

There is no single known cause of mast cell tumors in dogs. In most cases, they are thought to develop from a mix of genetic risk, age-related cellular changes, and tumor-specific mutations. Pet parents do not cause these tumors by grooming, bathing, feeding a certain food, or touching a lump too much.

One important molecular factor is mutation of the c-KIT gene in some tumors. KIT is a receptor involved in mast cell growth and survival. When it is abnormally activated, mast cells can multiply in an uncontrolled way. This matters clinically because some dogs with nonresectable or recurrent disease may be candidates for tyrosine kinase inhibitor drugs such as toceranib phosphate (Palladia), depending on the case and your vet's oncology plan.

Breed predisposition is well recognized. Boxers, Pugs, Boston Terriers, Rhodesian Ridgebacks, Golden Retrievers, Labrador Retrievers, Bulldogs, and Shar-Peis are commonly cited as higher-risk breeds. Shar-Peis are notable because they may develop mast cell tumors at a younger age and can have more aggressive disease behavior.

Most dogs diagnosed with cutaneous mast cell tumors are middle-aged to older, often around 8 to 10 years old, though younger dogs can be affected too. Because genetics play such a large role, prevention is limited. Early detection is the most practical way to improve outcomes.

The first step is usually a fine-needle aspirate (FNA). This is a quick, low-cost test done with a small needle in the exam room. Mast cells often have distinctive purple granules on cytology, so many mast cell tumors can be strongly suspected or diagnosed without sedation. This is one reason your vet may recommend sampling even a very ordinary-looking lump.

Aspirates help identify the tumor type, but they do not reliably determine grade. For that, your vet usually needs a biopsy or surgical excision submitted for histopathology. The pathology report may include Kiupel grade, Patnaik grade, mitotic index, whether tumor cells are in blood or lymphatic vessels, and whether the surgical margins are clean or incomplete.

If the tumor has higher-risk features, your vet may recommend staging. This often includes aspirating the regional lymph node, even if it feels normal, because lymph nodes are a common first site of spread. Depending on the case, staging may also include blood work, urinalysis, abdominal ultrasound to assess the liver and spleen, and sometimes additional imaging or bone marrow evaluation.

Some dogs also benefit from KIT pattern assessment or c-KIT mutation testing, especially when disease is recurrent, nonresectable, metastatic, or being considered for targeted therapy. Ask your vet for the exact pathology wording, the grade used, and whether the margins were complete. Those details shape the next decision more than the lump's appearance ever could.

Most mast cell tumors cannot be prevented, but they can often be found earlier. The most helpful habit is a monthly hands-on lump check at home. Run your hands over your dog's chest, belly, legs, armpits, groin, neck, and tail base. If you find a new lump, note the date, location, and approximate size, then book an exam rather than waiting to see whether it changes.

If your dog has already had one mast cell tumor, future vigilance matters even more. Some dogs develop additional mast cell tumors over time, and a new lump should not be assumed to be "the same old thing" without sampling. A simple aspirate is often the fastest way to sort out whether a mass is inflammatory, benign, or something that needs treatment.

After surgery or oncology treatment, follow your vet's recheck schedule closely. Watch the incision or treatment site for swelling, redness, drainage, or a new bump. Also monitor for vomiting, appetite changes, lethargy, bruising, or black stool, since mast cell disease can affect more than the skin.

A mast cell tumor diagnosis can feel overwhelming because the behavior of these tumors is so variable. The good news is that many dogs with low-grade, localized disease do very well. When disease is more complex, there are still multiple care paths. Conservative, standard, and advanced options can all be appropriate depending on your dog's tumor, overall health, and your family's goals.